Benefits of Oxford/AstraZeneca vaccine outweigh any risk, says EMA
European agency seeks to allay blood clot fears as Germany, France and Italy temporarily suspend useCoronavirus – latest updatesSee all our coronavirus coverageEurope ’s medicines regulator has moved to stifle spiralling concern about the Oxford/AstraZeneca vaccine, saying the shot’s benefits outweigh the risks after four major EU countries announced they were suspending its use.Germany, France, Italy and Spain temporarily halted inoculations with the vaccine on Monday after reported incidents of bleeding, blood clots and a low count of blood platelets in some people who had received the AstraZeneca shot.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Jon Henley and Sarah Boseley Tags: Coronavirus Vaccines and immunisation Germany World Health Organization France Italy Europe Infectious diseases Science AstraZeneca Pharmaceuticals industry Health policy Spain Source Type: news
More News: AstraZeneca | Bleeding | Coronavirus | COVID-19 | France Health | Germany Health | Infectious Diseases | International Medicine & Public Health | Italy Health | Science | Spain Health | Vaccines | WHO